IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis

Journal of Experimental Medicine

Volumn 212, Issue 13, 2015, Pages 2253-2266

  Pallangyo, Charles K ^a   Ziegler, Paul K ^a   Greten, Florian R ^a,b  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SCATTER FACTOR; SMAD7 PROTEIN; SMURF1 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CRE RECOMBINASE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; I KAPPA B KINASE; INTEGRASE; SCATTER FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CD4+ T LYMPHOCYTE; CELL DEATH; CELL PROLIFERATION; COLITIS; COLON CARCINOGENESIS; DOWN REGULATION; FIBROBLAST; GENE OVEREXPRESSION; HORMONE RELEASE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; INTESTINE TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; UPREGULATION; ACUTE DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOGENESIS; CELL LINEAGE; DEFICIENCY; DISEASE MODEL; GENETIC RECOMBINATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR VOLUME;

ACUTE DISEASE; ANIMALS; CARCINOGENESIS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; COLITIS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FIBROBLASTS; FORKHEAD TRANSCRIPTION FACTORS; HEPATOCYTE GROWTH FACTOR; I-KAPPA B KINASE; INFLAMMATION; INTEGRASES; INTESTINAL NEOPLASMS; MICE; PROTO-ONCOGENE PROTEINS C-MET; RECOMBINATION, GENETIC; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84956913971     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20150576     Document Type: Article

References (66)

1. Allen, M., and J. Louise Jones. 2011. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J. Pathol. 223:162-176. http://dx.doi.org/10.1002/path.2803
2. Andoh, A., S. Bamba, M. Brittan, Y. Fujiyama, and N.A. Wright. 2007. Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol. Ther. 114:94-106. http://dx.doi.org/10.1016/j.pharmthera.2006.12.004
3. Arlt, F., and U. Stein. 2009. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int. J. Biochem. Cell Biol. 41:2356-2359. http://dx.doi.org/10.1016/j.biocel.2009.08.001
4. Baugé, C., J. Attia, S. Leclercq, J.-P. Pujol, P. Galéra, and K. Boumédiene. 2008. Interleukin-1β up-regulation of Smad7 via NF-κB activation in human chondrocytes. Arthritis Rheum. 58:221-226. http://dx.doi.org/10.1002/art.23154
5. + regulatory T cells. Proc. Natl. Acad. Sci. USA. 107:6424-6429. http://dx.doi.org/10.1073/pnas.0912437107
6. Bhowmick, N.A., A. Chytil, D. Plieth, A.E. Gorska, N. Dumont, S. Shappell, M.K. Washington, E.G. Neilson, and H.L. Moses. 2004. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science. 303:848-851. http://dx.doi.org/10.1126/science.1090922
7. Bitzer, M., G. von Gersdorff, D. Liang, A. Dominguez-Rosales, A.A. Beg, M. Rojkind, and E.P. Böttinger. 2000. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev. 14:187-197.
8. Bollrath, J., T.J. Phesse, V.A. von Burstin, T. Putoczki, M. Bennecke, T. Bateman, T. Nebelsiek, T. Lundgren-May, O. Canli, S. Schwitalla, et al. 2009. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 15:91-102. http://dx.doi.org/10.1016/j.ccr.2009.01.002
9. Buckley, C.D., D. Pilling, J.M. Lord, A.N. Akbar, D. Scheel-Toellner, and M. Salmon. 2001. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22:199-204. http://dx.doi.org/10.1016/S1471-4906(01)01863-4
10. Bussolino, F., M.F. Di Renzo, M. Ziche, E. Bocchietto, M. Olivero, L. Naldini, G. Gaudino, L. Tamagnone, A. Coffer, and P.M. Comoglio. 1992. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119:629-641. http://dx.doi.org/10.1083/jcb.119.3.629
11. Calon, A., D.V.F. Tauriello, and E. Batlle. 2014. TGF-β in CAF-mediated tumor growth and metastasis. Semin. Cancer Biol. 25:15-22. http://dx.doi.org/10.1016/j.semcancer.2013.12.008
12. Calon, A., E. Lonardo, A. Berenguer-Llergo, E. Espinet, X. Hernando-Momblona, M. Iglesias, M. Sevillano, S. Palomo-Ponce, D.V.F. Tauriello, D. Byrom, et al. 2015. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat. Genet. 47:320-329. http://dx.doi.org/10.1038/ng.3225
13. Chen, W.-J., C.-C. Ho, Y.-L. Chang, H.-Y. Chen, C.-A. Lin, T.-Y. Ling, S.-L. Yu, S.-S. Yuan, Y.-J.L. Chen, C.-Y. Lin, et al. 2014. Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. Nat. Commun. 5:3472.
14. Cirri, P., and P. Chiarugi. 2012. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev. 31:195-208. http://dx.doi.org/10.1007/s10555-011-9340-x
15. Clark, R.A., and T.S. Kupper. 2007. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood. 109:194-202. http://dx.doi.org/10.1182/blood-2006-02-002873
16. Crawford, Y., I. Kasman, L. Yu, C. Zhong, X. Wu, Z. Modrusan, J. Kaminker, and N. Ferrara. 2009. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell. 15:21-34. http://dx.doi.org/10.1016/j.ccr.2008.12.004
17. De Boeck, A., A. Hendrix, D. Maynard, M. Van Bockstal, A. Daniëls, P. Pauwels, C. Gespach, M. Bracke, and O. De Wever. 2013. Differential secretome analysis of cancer-associated fibroblasts and bone marrow derived precursors to identify microenvironmental regulators of colon cancer progression. Proteomics. 13:379-388. http://dx.doi.org/10.1002/pmic.201200179
18. De Wever, O., P. Demetter, M. Mareel, and M. Bracke. 2008. Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer. 123:2229-2238. http://dx.doi.org/10.1002/ijc.23925
19. Eckmann, L., T. Nebelsiek, A.A. Fingerle, S.M. Dann, J. Mages, R. Lang, S. Robine, M.F. Kagnoff, R.M. Schmid, M. Karin, et al. 2008. Opposing functions of IKKβ during acute and chronic intestinal inflammation. Proc. Natl. Acad. Sci. USA. 105:15058-15063. http://dx.doi.org/10.1073/pnas.0808216105
20. Elenbaas, B., and R.A. Weinberg. 2001. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264:169-184.
21. Eliseev, R.A., E.M. Schwarz, M.J. Zuscik, R.J. O'Keefe, H. Drissi, and R.N. Rosier. 2006. Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFκB. Exp. Cell Res. 312:40-50.
22. Erez, N., M. Truitt, P. Olson, S.T. Arron, and D. Hanahan. 2010. Cancerassociated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner. Cancer Cell. 17:135-147.
23. Freudlsperger, C., Y. Bian, S. Contag Wise, J. Burnett, J. Coupar, X. Yang, Z. Chen, C. Van Waes, J. Burnett, J. Coupar, et al. 2013. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene. 32:1549-1559. http://dx.doi.org/10.1038/onc.2012.171
24. Gordon, J.R. 2000. TGFβ1 and TNFα secreted by mast cells stimulated via the FcεRI activate fibroblasts for high-level production of monocyte chemoattractant protein-1 (MCP-1). Cell. Immunol. 201:42-49. http://dx.doi.org/10.1006/cimm.2000.1631
25. Greten, F.R., L. Eckmann, T.F. Greten, J.M. Park, Z.-W. Li, L.J. Egan, M.F. Kagnoff, and M. Karin. 2004. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 118:285-296. http://dx.doi.org/10.1016/j.cell.2004.07.013
26. Greten, F.R., M.C. Arkan, J. Bollrath, L.-C. Hsu, J. Goode, C. Miething, S.I. Göktuna, M. Neuenhahn, J. Fierer, S. Paxian, et al. 2007. NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ. Cell. 130:918-931. http://dx.doi.org/10.1016/j.cell.2007.07.009
27. Hanahan, D., and L.M. Coussens. 2012. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 21:309-322. http://dx.doi.org/10.1016/j.ccr.2012.02.022
28. Hong, S., C. Lee, and S.-J. Kim. 2007. Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-κB pathway. Cancer Res. 67:9577-9583. http://dx.doi.org/10.1158/0008-5472.CAN-07-1179
29. Hoot, K.E., M. Oka, G. Han, E. Bottinger, Q. Zhang, and X.J. Wang. 2010. HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion. J. Clin. Invest. 120:3606-3616. http://dx.doi.org/10.1172/JCI43304
30. Jung, D.W., Z.M. Che, J. Kim, K. Kim, K.Y. Kim, D. Williams, and J. Kim. 2010. Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma:a pivotal role of CCL7. Int. J. Cancer. 127:332-344.
31. Karin, M. 2009. NF-κB as a critical link between inflammation and cancer. Cold Spring Harb. Perspect. Biol. 1:a000141. http://dx.doi.org/10.1101/cshperspect.a000141
32. Koliaraki, V., M. Roulis, and G. Kollias. 2012. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis. J. Clin. Invest. 122:4231-4242. http://dx.doi.org/10.1172/JCI63917
33. Koliaraki, V., M. Pasparakis, and G. Kollias. 2015. IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer. J. Exp. Med. http://dx.doi.org/10.1084/jem.20150576
34. Lewis, M.P., K.A. Lygoe, M.L. Nystrom, W.P. Anderson, P.M. Speight, J.F. Marshall, and G.J. Thomas. 2004. Tumour-derived TGF-β1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br. J. Cancer. 90:822-832. http://dx.doi.org/10.1038/sj.bjc.6601611
35. Liu, X., Q. Wang, G. Yang, C. Marando, H.K. Koblish, L.M. Hall, J.S. Fridman, E. Behshad, R. Wynn, Y. Li, et al. 2011. A novel kinase inhibitor, INCB28060, blocks c-MET-dependent signaling, neoplastic activities, and cross-talk with EGFR and HER-3. Clin. Cancer Res. 17:7127-7138. http://dx.doi.org/10.1158/1078-0432.CCR-11-1157
36. Liu, Y., Q. Li, and L. Zhu. 2012. Expression of the hepatocyte growth factor and c-Met in colon cancer: correlation with clinicopathological features and overall survival. Tumori. 98:105-112.
37. Nakamura, T., K. Sakai, T. Nakamura, and K. Matsumoto. 2011. Hepatocyte growth factor twenty years on: Much more than a growth factor. J. Gastroenterol. Hepatol. 26(Suppl 1):188-202. http://dx.doi.org/10.1111/j.1440-1746.2010.06549.x
38. Ogura, N., M. Tobe, H. Sakamaki, H. Nagura, H. Hosaka, M. Akiba, Y. Abiko, and T. Kondoh. 2004. Interleukin-1β increases RAN TES gene expression and production in synovial fibroblasts from human temporomandibular joint. J. Oral Pathol. Med. 33:629-633. http://dx.doi.org/10.1111/j.1600-0714.2004.00260.x
39. Öhlund, D., E. Elyada, and D. Tuveson. 2014. Fibroblast heterogeneity in the cancer wound. J. Exp. Med. 211:1503-1523.
40. Okunishi, K., M. Dohi, K. Fujio, K. Nakagome, Y. Tabata, T. Okasora, M. Seki, M. Shibuya, M. Imamura, H. Harada, et al. 2007. Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J. Immunol. 179:5504-5513. http://dx.doi.org/10.4049/jimmunol.179.8.5504
41. Organ, S.L., and M.-S. Tsao. 2011. An overview of the c-MET signaling pathway. Ther. Adv. Med. Oncol. S7-S19. http://dx.doi.org/10.1177/1758834011422556
42. Orimo, A., P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson, and R.A. Weinberg. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 121:335-348. http://dx.doi.org/10.1016/j.cell.2005.02.034
43. Östman, A., and M. Augsten. 2009. Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. Curr. Opin. Genet. Dev. 19:67-73.
44. Özdemir, B.C., T. Pentcheva-Hoang, J.L. Carstens, X. Zheng, C.-C. Wu, T.R. Simpson, H. Laklai, H. Sugimoto, C. Kahlert, S.V. Novitskiy, et al. 2014. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 25:719-734. http://dx.doi.org/10.1016/j.ccr.2014.04.005
45. Pang, G., L. Couch, R. Batey, R. Clancy, and A. Cripps. 1994. GM-CSF, IL-1α, IL-1β, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-α. Clin. Exp. Immunol. 96:437-443.
46. Pilling, D., A.N. Akbar, J. Girdlestone, C.H. Orteu, N.J. Borthwick, N. Amft, D. Scheel-Toellner, C.D. Buckley, and M. Salmon. 1999. Interferon-β mediates stromal cell rescue of T cells from apoptosis. Eur. J. Immunol. 29:1041-1050. http://dx.doi.org/10.1002/(SICI)1521-4141(199903)29 :03<1041::AID-IMM
47. Ponzetto, C., A. Bardelli, Z. Zhen, F. Maina, P. dalla Zonca, S. Giordano, A. Graziani, G. Panayotou, and P.M. Comoglio. 1994. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell. 77:261-271.
48. Proto, J.D., Y. Tang, A. Lu, W.C.W. Chen, E. Stahl, M. Poddar, S.A. Beckman, P.D. Robbins, L.J. Nidernhofer, K. Imbrogno, et al. 2015. NF-κB inhibition reveals a novel role for HGF during skeletal muscle repair. Cell Death Dis. 6:e1730.
49. Quante, M., S.P. Tu, H. Tomita, T. Gonda, S.S.W. Wang, S. Takashi, G.H. Baik, W. Shibata, B. Diprete, K.S. Betz, et al. 2011. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 19:257-272. http://dx.doi.org/10.1016/j.ccr.2011.01.020
50. Räsänen, K., and A. Vaheri. 2010. Activation of fibroblasts in cancer stroma. Exp. Cell Res. 316:2713-2722. http://dx.doi.org/10.1016/j.yexcr.2010.04.032
51. Rhim, A.D., P.E. Oberstein, D.H. Thomas, E.T. Mirek, C.F. Palermo, S.A. Sastra, E.N. Dekleva, T. Saunders, C.P. Becerra, I.W. Tattersall, et al. 2014. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 25:735-747.
52. Schwitalla, S., A.A. Fingerle, P. Cammareri, T. Nebelsiek, S.I. Göktuna, P.K. Ziegler, O. Canli, J. Heijmans, D.J. Huels, G. Moreaux, et al. 2013a. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell. 152:25-38. http://dx.doi.org/10.1016/j.cell.2012.12.012
53. Schwitalla, S., P.K. Ziegler, D. Horst, V. Becker, I. Kerle, Y. Begus-Nahrmann, A. Lechel, K.L. Rudolph, R. Langer, J. Slotta-Huspenina, et al. 2013b. Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors. Cancer Cell. 23:93-106. http://dx.doi.org/10.1016/j.ccr.2012.11.014
54. Servais, C., and N. Erez. 2013. From sentinel cells to inflammatory culprits:cancer-associated fibroblasts in tumour-related inflammation. J. Pathol. 229:198-207.
55. Stein, U., W. Walther, F. Arlt, H. Schwabe, J. Smith, I. Fichtner, W. Birchmeier, and P.M. Schlag. 2009. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat. Med. 15:59-67. http://dx.doi.org/10.1038/nm.1889
56. Toullec, A., D. Gerald, G. Despouy, B. Bourachot, M. Cardon, S. Lefort, M. Richardson, G. Rigaill, M.C. Parrini, C. Lucchesi, et al. 2010. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol. Med. 2:211-230. http://dx.doi.org/10.1002/emmm.201000073
57. Trusolino, L., A. Bertotti, and P.M. Comoglio. 2010. MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell Biol. 11:834-848.
58. Valencia, T., J.Y. Kim, S. Abu-Baker, J. Moscat-Pardos, C.S. Ahn, M. Reina-Campos, A. Duran, E.A. Castilla, C.M. Metallo, M.T. Diaz-Meco, and J. Moscat. 2014. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell. 26:121-135. http://dx.doi.org/10.1016/j.ccr.2014.05.004
59. Vermeulen, L., F. De Sousa E Melo, M. van der Heijden, K. Cameron, J.H. de Jong, T. Borovski, J.B. Tuynman, M. Todaro, C. Merz, H. Rodermond, et al. 2010. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 12:468-476. http://dx.doi.org/10.1038/ncb2048
60. Vougioukalaki, M., D.C. Kanellis, K. Gkouskou, and A.G. Eliopoulos. 2011. Tpl2 kinase signal transduction in inflammation and cancer. Cancer Lett. 304:80-89. http://dx.doi.org/10.1016/j.canlet.2011.02.004
61. Yan, X., Z. Liu, and Y. Chen. 2009. Regulation of TGF-βsignaling by Smad7. Acta Biochim. Biophys. Sin. (Shanghai). 41:263-272. http://dx.doi.org/10.1093/abbs/gmp018
62. Yang, L., Y. Pang, and H.L. Moses. 2010. TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 31:220-227. http://dx.doi.org/10.1016/j.it.2010.04.002
63. Yin, J., J.H. Lee, J. Zhang, Z. Gao, V.Y. Polotsky, and J. Ye. 2014. Regulation of hepatocyte growth factor expression by NF-κB and PPARγ in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 306:E929-E936. http://dx.doi.org/10.1152/ajpendo.00687.2013
64. Yucel-Lindberg, T., and G. Brunius. 2006. Epidermal growth factor synergistically enhances interleukin-8 production in human gingival fibroblasts stimulated with interleukin-1β. Arch. Oral Biol. 51:892-898. http://dx.doi.org/10.1016/j.archoralbio.2006.03.004
65. + fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation. Am. J. Pathol. 178:382-390. http://dx.doi.org/10.1016/j.ajpath.2010.11.017
66. Zheng, B., Z. Zhang, C.M. Black, B. de Crombrugghe, and C.P. Denton. 2002. Ligand-dependent genetic recombination in fibroblasts: a potentially powerful technique for investigating gene function in fibrosis. Am. J. Pathol. 160:1609-1617. http://dx.doi.org/10.1016/S0002-9440(10)61108-X